BSL-3 Flow, Biomarker and Imaging Core (FBI)
Core leader: Greg Sempowski
The BSL3 Host Pathogen Interaction Core (FBI Core) is comprised of technologies and services offered through the NIAID-funded Regional Biocontainment Laboratory at Duke University in conjunction with existing shared resource facilities in the Duke University Human Vaccine Institute, which oversees operation of the RBL. This BSL3 SERCEB FBI Core routinely provides investigators with high quality flow cytometry, in vivo imaging, protein array analysis, and complete blood count/hematologic analysis for basic and applied research efforts.
During year three we provided services to eleven SERCEB-funded investigators, initatied a TRANS-RCE collaboration with Dr. Janko Nickolich-Zugich (Arizona), and used core resources for assay optimization, protocol development and safety SOP development.
Overall the SERCEB FBI core offers state-of-the-art BSL-2/3 flow cytometry, biomarker profiling and live in vivo imaging. The significance of our work is that we offer one stop shopping within the RBL at Duke for, safe, secure, comprehensive high-quality immune monitoring. Core services are available to all SERCEB/RCE investigators, other NIAID-funded investigators outside the center and other qualified investigators in the region on a fee-for–service basis.
For additional information on SERCEB FBI services see
To register for services, contact Greg Sempowski
Current SERCEB rates: